| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.83e-06 | 188 | 107 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 1.69e-04 | 4 | 107 | 2 | GO:0001010 | |
| GeneOntologyBiologicalProcess | bone development | 8.29e-06 | 264 | 105 | 9 | GO:0060348 | |
| GeneOntologyCellularComponent | extracellular matrix | DPT SPARC GDF15 KERA LAMB3 MUC5B SSPOP LRIG3 THBS1 FBN1 TIMP2 ADAMTS9 OTOGL SPON1 CCN2 MUC4 | 1.98e-07 | 656 | 106 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | DPT SPARC GDF15 KERA LAMB3 MUC5B SSPOP LRIG3 THBS1 FBN1 TIMP2 ADAMTS9 OTOGL SPON1 CCN2 MUC4 | 2.06e-07 | 658 | 106 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | DPT SPARC GDF15 LAMB3 SSPOP THBS1 FBN1 TIMP2 ADAMTS9 SPON1 CCN2 MUC4 | 1.58e-05 | 530 | 106 | 12 | GO:0062023 |
| MousePheno | abnormal hindlimb morphology | PAPPA2 GDF5 SPARC HCAR1 MC3R C1RL PGAP4 LRRK1 SLC10A7 TG THBS1 FBN1 TIMP2 SPON1 PAPPA CCN2 | 3.15e-07 | 576 | 85 | 16 | MP:0000556 |
| MousePheno | abnormal pelvic girdle bone morphology | 9.44e-07 | 87 | 85 | 7 | MP:0004509 | |
| MousePheno | abnormal tibia morphology | PAPPA2 GDF5 SPARC HCAR1 C1RL PGAP4 LRRK1 SLC10A7 TG FBN1 PAPPA CCN2 | 2.63e-06 | 375 | 85 | 12 | MP:0000558 |
| MousePheno | abnormal hindlimb zeugopod morphology | PAPPA2 GDF5 SPARC HCAR1 C1RL PGAP4 LRRK1 SLC10A7 TG FBN1 PAPPA CCN2 | 3.09e-06 | 381 | 85 | 12 | MP:0003857 |
| MousePheno | abnormal limb long bone morphology | PAPPA2 GDF5 SPARC HCAR1 MC3R C1RL PGAP4 LRRK1 SLC10A7 TG FBN1 SPON1 PAPPA CCN2 | 7.56e-06 | 568 | 85 | 14 | MP:0011504 |
| MousePheno | abnormal limb morphology | MYT1L PAPPA2 GDF5 SPARC HCAR1 MC3R C1RL PGAP4 LRRK1 SLC10A7 TG HIVEP3 LRIG3 THBS1 FBN1 TIMP2 SPON1 PAPPA CCN2 | 9.92e-06 | 1028 | 85 | 19 | MP:0002109 |
| MousePheno | abnormal radius morphology | 1.02e-05 | 82 | 85 | 6 | MP:0000552 | |
| MousePheno | abnormal limb bone morphology | PAPPA2 GDF5 SPARC HCAR1 MC3R C1RL PGAP4 LRRK1 SLC10A7 TG FBN1 SPON1 PAPPA CCN2 | 1.10e-05 | 587 | 85 | 14 | MP:0002115 |
| MousePheno | abnormal forelimb zeugopod morphology | 3.57e-05 | 102 | 85 | 6 | MP:0003855 | |
| MousePheno | limbs/digits/tail phenotype | MYT1L PAPPA2 GDF5 SPARC HCAR1 MC3R C1RL PGAP4 LRRK1 SLC10A7 TG HIVEP3 LRIG3 THBS1 FBN1 TIMP2 ADAMTS9 SPON1 PAPPA CCN2 | 4.96e-05 | 1258 | 85 | 20 | MP:0005371 |
| MousePheno | abnormal long bone morphology | PAPPA2 GDF5 SPARC HCAR1 MC3R C1RL PGAP4 LRRK1 SLC10A7 TG FBN1 SPON1 PAPPA CCN2 | 5.24e-05 | 676 | 85 | 14 | MP:0003723 |
| MousePheno | short radius | 9.85e-05 | 40 | 85 | 4 | MP:0004355 | |
| MousePheno | decreased radius size | 9.85e-05 | 40 | 85 | 4 | MP:0030886 | |
| MousePheno | abnormal forelimb morphology | 1.19e-04 | 182 | 85 | 7 | MP:0000550 | |
| MousePheno | short femur | 1.22e-04 | 127 | 85 | 6 | MP:0003109 | |
| MousePheno | decreased femur size | 1.38e-04 | 130 | 85 | 6 | MP:0030825 | |
| MousePheno | abnormal ulna morphology | 1.56e-04 | 84 | 85 | 5 | MP:0005108 | |
| MousePheno | decreased lean body mass | 1.75e-04 | 407 | 85 | 10 | MP:0003961 | |
| MousePheno | abnormal forelimb stylopod morphology | 2.40e-04 | 92 | 85 | 5 | MP:0003854 | |
| MousePheno | abnormal humerus morphology | 2.40e-04 | 92 | 85 | 5 | MP:0005296 | |
| MousePheno | short tibia | 2.57e-04 | 274 | 85 | 8 | MP:0002764 | |
| MousePheno | abnormal appendicular skeleton morphology | PAPPA2 GDF5 SPARC HCAR1 MC3R C1RL PGAP4 LRRK1 SLC10A7 SSPOP TG FBN1 SPON1 PAPPA CCN2 | 2.96e-04 | 896 | 85 | 15 | MP:0009250 |
| MousePheno | abnormal femur morphology | 3.21e-04 | 214 | 85 | 7 | MP:0000559 | |
| MousePheno | abnormal hindlimb stylopod morphology | 3.30e-04 | 215 | 85 | 7 | MP:0003856 | |
| MousePheno | decreased susceptibility to osteoporosis | 3.61e-04 | 5 | 85 | 2 | MP:0012072 | |
| MousePheno | abnormal susceptibility to osteoporosis | 3.61e-04 | 5 | 85 | 2 | MP:0012070 | |
| MousePheno | abnormal trabecular bone morphology | 3.67e-04 | 289 | 85 | 8 | MP:0000130 | |
| MousePheno | abnormal skeleton physiology | SELP GDF5 SPARC PGAP4 LRRK1 SLC10A7 HIVEP3 FZD9 FBN1 SPON1 PAPPA CCN2 | 4.20e-04 | 632 | 85 | 12 | MP:0001533 |
| MousePheno | abnormal bone volume | 6.42e-04 | 173 | 85 | 6 | MP:0010874 | |
| Domain | Sushi_SCR_CCP_dom | 2.66e-08 | 57 | 103 | 7 | IPR000436 | |
| Domain | Sushi | 4.03e-07 | 52 | 103 | 6 | PF00084 | |
| Domain | CCP | 5.06e-07 | 54 | 103 | 6 | SM00032 | |
| Domain | SUSHI | 6.31e-07 | 56 | 103 | 6 | PS50923 | |
| Domain | TSP_1 | 1.28e-06 | 63 | 103 | 6 | PF00090 | |
| Domain | TSP1 | 1.54e-06 | 65 | 103 | 6 | SM00209 | |
| Domain | TSP1_rpt | 1.54e-06 | 65 | 103 | 6 | IPR000884 | |
| Domain | TSP1 | 1.54e-06 | 65 | 103 | 6 | PS50092 | |
| Domain | CTCK_2 | 1.01e-05 | 25 | 103 | 4 | PS01225 | |
| Domain | Peptidase_M43 | 3.01e-05 | 2 | 103 | 2 | IPR008754 | |
| Domain | Peptidase_M43 | 3.01e-05 | 2 | 103 | 2 | PF05572 | |
| Domain | VWFC_1 | 4.49e-05 | 36 | 103 | 4 | PS01208 | |
| Domain | VWFC_2 | 5.57e-05 | 38 | 103 | 4 | PS50184 | |
| Domain | VWC | 5.57e-05 | 38 | 103 | 4 | SM00214 | |
| Domain | uDENN | 5.67e-05 | 14 | 103 | 3 | SM00800 | |
| Domain | uDENN | 7.06e-05 | 15 | 103 | 3 | PF03456 | |
| Domain | VWF_dom | 8.31e-05 | 42 | 103 | 4 | IPR001007 | |
| Domain | DENN | 8.66e-05 | 16 | 103 | 3 | SM00799 | |
| Domain | VWF_type-D | 8.66e-05 | 16 | 103 | 3 | IPR001846 | |
| Domain | DENN | 8.66e-05 | 16 | 103 | 3 | PF02141 | |
| Domain | VWFD | 8.66e-05 | 16 | 103 | 3 | PS51233 | |
| Domain | dDENN | 8.66e-05 | 16 | 103 | 3 | PF03455 | |
| Domain | UDENN | 8.66e-05 | 16 | 103 | 3 | PS50946 | |
| Domain | DDENN | 8.66e-05 | 16 | 103 | 3 | PS50947 | |
| Domain | VWD | 8.66e-05 | 16 | 103 | 3 | SM00216 | |
| Domain | dDENN | 8.66e-05 | 16 | 103 | 3 | SM00801 | |
| Domain | dDENN_dom | 8.66e-05 | 16 | 103 | 3 | IPR005112 | |
| Domain | uDENN_dom | 8.66e-05 | 16 | 103 | 3 | IPR005113 | |
| Domain | DENN | 8.66e-05 | 16 | 103 | 3 | PS50211 | |
| Domain | DENN_dom | 8.66e-05 | 16 | 103 | 3 | IPR001194 | |
| Domain | VWD | 8.66e-05 | 16 | 103 | 3 | PF00094 | |
| Domain | Myxo_disulph_rpt | 9.00e-05 | 3 | 103 | 2 | IPR011936 | |
| Domain | CTCK_1 | 1.25e-04 | 18 | 103 | 3 | PS01185 | |
| Domain | LamGL | 1.79e-04 | 4 | 103 | 2 | SM00560 | |
| Domain | LamG-like | 1.79e-04 | 4 | 103 | 2 | IPR006558 | |
| Domain | VWA_N | 2.98e-04 | 5 | 103 | 2 | IPR013608 | |
| Domain | VWA_N | 2.98e-04 | 5 | 103 | 2 | PF08399 | |
| Domain | Cys_knot_C | 3.43e-04 | 25 | 103 | 3 | IPR006207 | |
| Domain | VWC | 4.83e-04 | 28 | 103 | 3 | PF00093 | |
| Domain | Notch_dom | 6.21e-04 | 7 | 103 | 2 | IPR000800 | |
| Domain | Notch | 6.21e-04 | 7 | 103 | 2 | PF00066 | |
| Domain | NL | 6.21e-04 | 7 | 103 | 2 | SM00004 | |
| Domain | Frizzled | 1.60e-03 | 11 | 103 | 2 | IPR000539 | |
| Domain | Frizzled | 1.60e-03 | 11 | 103 | 2 | PF01534 | |
| Domain | Frizzled | 1.60e-03 | 11 | 103 | 2 | SM01330 | |
| Domain | C8 | 1.92e-03 | 12 | 103 | 2 | PF08742 | |
| Domain | TIL | 1.92e-03 | 12 | 103 | 2 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 2.26e-03 | 13 | 103 | 2 | IPR014853 | |
| Domain | C8 | 2.26e-03 | 13 | 103 | 2 | SM00832 | |
| Domain | TIL_dom | 2.62e-03 | 14 | 103 | 2 | IPR002919 | |
| Domain | EGF_1 | 2.90e-03 | 255 | 103 | 6 | PS00022 | |
| Domain | Glyco_hormone_CN | 3.02e-03 | 15 | 103 | 2 | IPR006208 | |
| Domain | Cys_knot | 3.02e-03 | 15 | 103 | 2 | PF00007 | |
| Domain | Frizzled/SFRP | 3.44e-03 | 16 | 103 | 2 | IPR015526 | |
| Domain | EGF_2 | 3.50e-03 | 265 | 103 | 6 | PS01186 | |
| Domain | VWC_out | 4.84e-03 | 19 | 103 | 2 | SM00215 | |
| Domain | FRI | 5.36e-03 | 20 | 103 | 2 | SM00063 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 9.76e-08 | 68 | 79 | 7 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.63e-07 | 109 | 79 | 8 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.88e-07 | 111 | 79 | 8 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.31e-06 | 143 | 79 | 8 | M27275 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.41e-06 | 39 | 79 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.41e-06 | 39 | 79 | 5 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 7.70e-05 | 250 | 79 | 8 | M27554 | |
| Pubmed | 1.39e-07 | 75 | 109 | 6 | 20637190 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.22e-06 | 248 | 109 | 8 | 24006456 | |
| Pubmed | 1.81e-06 | 64 | 109 | 5 | 22261194 | ||
| Pubmed | 3.59e-06 | 130 | 109 | 6 | 12421765 | ||
| Pubmed | MEGF10 and MEGF11 mediate homotypic interactions required for mosaic spacing of retinal neurons. | 4.43e-06 | 35 | 109 | 4 | 22407321 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.84e-06 | 86 | 109 | 5 | 28327460 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21586553 | ||
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 9.73e-06 | 2 | 109 | 2 | 19415763 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24462860 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15007167 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23280549 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 14690056 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25016703 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11513734 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15634279 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12658547 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21978691 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19698122 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 29144175 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 37330435 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24598770 | ||
| Pubmed | Differential expression of nanog1 and nanogp8 in colon cancer cells. | 9.73e-06 | 2 | 109 | 2 | 22079639 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 3402455 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24069146 | ||
| Pubmed | Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. | 9.73e-06 | 2 | 109 | 2 | 21136380 | |
| Pubmed | 1.06e-05 | 14 | 109 | 3 | 36347239 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | CFH GDF5 GDF15 KIF12 CR2 ULBP3 F13B MADD MACF1 TNFRSF19 CCN2 CCL24 | 1.11e-05 | 824 | 109 | 12 | 20237496 |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 1.35e-05 | 247 | 109 | 7 | 39238192 | |
| Pubmed | 1.63e-05 | 16 | 109 | 3 | 31669249 | ||
| Pubmed | 1.96e-05 | 175 | 109 | 6 | 28071719 | ||
| Pubmed | Murine inner cell mass-derived lineages depend on Sall4 function. | 2.36e-05 | 18 | 109 | 3 | 17060609 | |
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 2.91e-05 | 3 | 109 | 2 | 30814124 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 2.91e-05 | 3 | 109 | 2 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 2.91e-05 | 3 | 109 | 2 | 18177668 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 2.91e-05 | 3 | 109 | 2 | 17211451 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 15502159 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 2.91e-05 | 3 | 109 | 2 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 2.91e-05 | 3 | 109 | 2 | 23054952 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 2.91e-05 | 3 | 109 | 2 | 19800316 | |
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 2.91e-05 | 3 | 109 | 2 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 2.91e-05 | 3 | 109 | 2 | 23329853 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 23390502 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 2.91e-05 | 3 | 109 | 2 | 26733157 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 2.91e-05 | 3 | 109 | 2 | 19582141 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 19703398 | ||
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 2.91e-05 | 3 | 109 | 2 | 28636920 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 20539761 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18584034 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 21969378 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 20661723 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 29245050 | ||
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 2.91e-05 | 3 | 109 | 2 | 15494369 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 2.91e-05 | 3 | 109 | 2 | 14728807 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 32934754 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 19828624 | ||
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 2.91e-05 | 3 | 109 | 2 | 21194951 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22388986 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 16791199 | ||
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 2.91e-05 | 3 | 109 | 2 | 18024963 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 27125671 | ||
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 2.91e-05 | 3 | 109 | 2 | 25410303 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 33334884 | ||
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 2.91e-05 | 3 | 109 | 2 | 17360937 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 26760119 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 2.91e-05 | 3 | 109 | 2 | 24461999 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 2.91e-05 | 3 | 109 | 2 | 30837263 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 2.91e-05 | 3 | 109 | 2 | 27939294 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18442017 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 2.91e-05 | 3 | 109 | 2 | 22172669 | |
| Pubmed | Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. | 2.91e-05 | 3 | 109 | 2 | 18805800 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 19447925 | ||
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 2.91e-05 | 3 | 109 | 2 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 2.91e-05 | 3 | 109 | 2 | 17554338 | |
| Pubmed | Genetic Study of IL6, GDF5 and PAPPA2 in Association with Developmental Dysplasia of the Hip. | 2.91e-05 | 3 | 109 | 2 | 34203285 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22202776 | ||
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 2.91e-05 | 3 | 109 | 2 | 16259959 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 12609610 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 24227785 | ||
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 2.91e-05 | 3 | 109 | 2 | 23770853 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 3782802 | ||
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 2.91e-05 | 3 | 109 | 2 | 24527385 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18086680 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 16270194 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 17204467 | ||
| Pubmed | Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR. | 2.91e-05 | 3 | 109 | 2 | 29532882 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 23200040 | ||
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 2.91e-05 | 3 | 109 | 2 | 26751055 | |
| Pubmed | Altered placental expression of PAPPA2 does not affect birth weight in mice. | 2.91e-05 | 3 | 109 | 2 | 20642865 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 2.91e-05 | 3 | 109 | 2 | 17352742 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 2.91e-05 | 3 | 109 | 2 | 25005472 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 16773043 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 23071603 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 21119109 | ||
| Cytoband | 1q32 | 2.22e-04 | 49 | 109 | 3 | 1q32 | |
| Cytoband | 9p24.3 | 4.99e-04 | 14 | 109 | 2 | 9p24.3 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.77e-09 | 57 | 68 | 7 | 1179 | |
| GeneFamily | Pappalysins|Sushi domain containing | 1.39e-05 | 2 | 68 | 2 | 897 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.10e-04 | 25 | 68 | 3 | 504 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 7.50e-04 | 11 | 68 | 2 | 286 | |
| GeneFamily | CD molecules|Mucins | 2.79e-03 | 21 | 68 | 2 | 648 | |
| Coexpression | NABA_MATRISOME | PAPPA2 GDF5 DPT SPARC GDF15 KERA LAMB3 MUC5B SSPOP F13B THBS1 FBN1 TIMP2 ADAMTS9 OTOGL SPON1 PAPPA CCN2 CCL24 MUC4 | 4.17e-09 | 1008 | 107 | 20 | MM17056 |
| Coexpression | NABA_MATRISOME | PAPPA2 GDF5 DPT SPARC GDF15 KERA LAMB3 MUC5B SSPOP F13B THBS1 FBN1 TIMP2 ADAMTS9 SPON1 PAPPA CCN2 CCL24 MUC4 | 3.22e-08 | 1026 | 107 | 19 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 9.30e-08 | 191 | 107 | 9 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 1.66e-07 | 270 | 107 | 10 | MM17057 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | DPT SPARC ETS2 LAMB3 PGAP4 CACHD1 DENND2B FBN1 TIMP2 SPON1 TNS4 MUC4 | 8.44e-07 | 493 | 107 | 12 | M19391 |
| Coexpression | KIM_GLIS2_TARGETS_UP | 1.45e-06 | 86 | 107 | 6 | M2259 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.47e-06 | 196 | 107 | 8 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.98e-06 | 275 | 107 | 9 | M5884 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 3.94e-06 | 102 | 107 | 6 | MM1064 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 8.70e-06 | 117 | 107 | 6 | M39300 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 1.12e-05 | 185 | 107 | 7 | M42503 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 1.43e-05 | 192 | 107 | 7 | M42501 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.52e-05 | 194 | 107 | 7 | M39122 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | SELP DPT ABCA1 SPARC ETS2 PGAP4 CR2 THBS1 SPON1 MACF1 CCN2 MUC4 | 3.91e-05 | 721 | 107 | 12 | M1999 |
| Coexpression | HAY_BONE_MARROW_STROMAL | CFH DPT CACHD1 THSD7B DENND2B LRIG3 FBN1 ADAMTS9 OTOGL PAPPA TNFRSF19 CCN2 | 7.06e-05 | 767 | 107 | 12 | M39209 |
| Coexpression | RAO_BOUND_BY_SALL4 | 7.10e-05 | 247 | 107 | 7 | MM1081 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES | 1.06e-04 | 114 | 107 | 5 | M40293 | |
| Coexpression | IL21_UP.V1_DN | 1.18e-04 | 186 | 107 | 6 | M2824 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 1.24e-04 | 465 | 107 | 9 | M39066 | |
| Coexpression | JEON_SMAD6_TARGETS_UP | 1.26e-04 | 24 | 107 | 3 | M4592 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.35e-04 | 120 | 107 | 5 | M42505 | |
| Coexpression | TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL | 1.47e-04 | 65 | 107 | 4 | M41673 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.47e-04 | 65 | 107 | 4 | M39309 | |
| Coexpression | SAUL_SEN_MAYO | 1.52e-04 | 123 | 107 | 5 | MM16098 | |
| Coexpression | SAUL_SEN_MAYO | 1.58e-04 | 124 | 107 | 5 | M45803 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN | 1.70e-04 | 199 | 107 | 6 | M9941 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN | 1.75e-04 | 200 | 107 | 6 | M6404 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 1.75e-04 | 200 | 107 | 6 | M6096 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 2.08e-04 | 294 | 107 | 7 | M1804 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | CFH ABCA1 GDF15 RNF44 ETS2 LAMB3 C1RL THBS1 ASAP2 TIMP2 ADAMTS9 MACF1 AKAP13 CCN2 MAP3K21 | 2.11e-04 | 1276 | 107 | 15 | M39173 |
| Coexpression | HALLMARK_COAGULATION | 2.60e-04 | 138 | 107 | 5 | M5946 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 8.22e-06 | 97 | 104 | 6 | GSM777043_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.40e-05 | 293 | 104 | 9 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | PAPPA2 DOCK8 KIF12 NCOR1 THBS1 ADAMTS9 SPON1 MED12L AKAP13 MAP3K21 | 2.84e-05 | 402 | 104 | 10 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 6.15e-05 | 85 | 104 | 5 | GSM777067_100 | |
| ToppCell | medial-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.57e-09 | 199 | 109 | 9 | 95aae608fa35a9c82b12c6f18937ce636750ca44 | |
| ToppCell | medial-mesenchymal-Myofibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.57e-09 | 199 | 109 | 9 | e25acdb5809aaff631cb06dbe4c7e59549a0bdb9 | |
| ToppCell | medial-mesenchymal-Myofibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.57e-09 | 199 | 109 | 9 | 9ebf4822ff9fa08574edec5dbf4f2a1488f34b1d | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.64e-09 | 200 | 109 | 9 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-08 | 181 | 109 | 8 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-08 | 181 | 109 | 8 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.72e-08 | 183 | 109 | 8 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-08 | 183 | 109 | 8 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-08 | 192 | 109 | 8 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.50e-08 | 192 | 109 | 8 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-08 | 192 | 109 | 8 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-08 | 195 | 109 | 8 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-08 | 195 | 109 | 8 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-08 | 195 | 109 | 8 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-08 | 195 | 109 | 8 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-08 | 195 | 109 | 8 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.30e-08 | 199 | 109 | 8 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.30e-08 | 199 | 109 | 8 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.43e-08 | 200 | 109 | 8 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | 390C-Fibroblasts|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.43e-08 | 200 | 109 | 8 | 3abe0f017fee6057ba73bd661a2bc8ec9e2bfe38 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.43e-08 | 200 | 109 | 8 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.43e-08 | 200 | 109 | 8 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-07 | 175 | 109 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 2.97e-07 | 179 | 109 | 7 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.71e-07 | 185 | 109 | 7 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.71e-07 | 185 | 109 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | P03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.71e-07 | 185 | 109 | 7 | a07dbe1f76e40734a28826423a5cc64b8e56af5e | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.14e-07 | 188 | 109 | 7 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.44e-07 | 190 | 109 | 7 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.44e-07 | 190 | 109 | 7 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.60e-07 | 191 | 109 | 7 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.60e-07 | 191 | 109 | 7 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.60e-07 | 191 | 109 | 7 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-07 | 191 | 109 | 7 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-07 | 193 | 109 | 7 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-07 | 193 | 109 | 7 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.29e-07 | 195 | 109 | 7 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.29e-07 | 195 | 109 | 7 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.29e-07 | 195 | 109 | 7 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.29e-07 | 195 | 109 | 7 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.29e-07 | 195 | 109 | 7 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.29e-07 | 195 | 109 | 7 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.29e-07 | 195 | 109 | 7 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.48e-07 | 196 | 109 | 7 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-07 | 196 | 109 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-07 | 196 | 109 | 7 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.67e-07 | 197 | 109 | 7 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.67e-07 | 197 | 109 | 7 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.86e-07 | 198 | 109 | 7 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.86e-07 | 198 | 109 | 7 | e0ef49ec0f87cc87b45efa297b9ff6c35b7a2ba9 | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-07 | 198 | 109 | 7 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.86e-07 | 198 | 109 | 7 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.86e-07 | 198 | 109 | 7 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-07 | 198 | 109 | 7 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | distal-Epithelial-Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.86e-07 | 198 | 109 | 7 | dda0bf3a48f738df590ce23b891d82be19e10d66 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.86e-07 | 198 | 109 | 7 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.06e-07 | 199 | 109 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.06e-07 | 199 | 109 | 7 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.06e-07 | 199 | 109 | 7 | cb3c04b91c8e8080137823b11c76ca0a2adda52d | |
| ToppCell | distal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.06e-07 | 199 | 109 | 7 | b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.27e-07 | 200 | 109 | 7 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | COVID-19-Fibroblasts-Pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.27e-07 | 200 | 109 | 7 | 73e01b7bc43320a991c67a4fd0c04708f893c7ea | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.27e-07 | 200 | 109 | 7 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-07 | 200 | 109 | 7 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-07 | 200 | 109 | 7 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.27e-07 | 200 | 109 | 7 | 58c5870030192b337e7d883044948634fcd17d2c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.27e-07 | 200 | 109 | 7 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.27e-07 | 200 | 109 | 7 | 05486d86868f6a93429226063cca270f00dd8714 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.27e-07 | 200 | 109 | 7 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.27e-07 | 200 | 109 | 7 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-07 | 200 | 109 | 7 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.27e-07 | 200 | 109 | 7 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | proximal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.27e-07 | 200 | 109 | 7 | 869d45b71efd395d050873db5fee2ed0443d5e6f | |
| ToppCell | Tracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-07 | 200 | 109 | 7 | f74b9b0e27afedd589e828d30194e8417029817a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.27e-07 | 200 | 109 | 7 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-07 | 200 | 109 | 7 | 5fdca7959134a5c8e06e5d6d14aafe34b963aef2 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.27e-07 | 200 | 109 | 7 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.27e-07 | 200 | 109 | 7 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.27e-07 | 200 | 109 | 7 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 4.04e-06 | 171 | 109 | 6 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.32e-06 | 173 | 109 | 6 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-06 | 174 | 109 | 6 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cbr2_(Mural.Rgs5Acta2.Cbr2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.54e-06 | 99 | 109 | 5 | 0e2f6ba2261cc289f8f4aec5aac3051f6321e041 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cbr2_(Mural.Rgs5Acta2.Cbr2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.54e-06 | 99 | 109 | 5 | ce9d6d9b82bdc1ebb58b0b6e04abfb022dd1de88 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.77e-06 | 176 | 109 | 6 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.77e-06 | 176 | 109 | 6 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.26e-06 | 179 | 109 | 6 | d5b9c610c1519804b1753fed1b505293ea590867 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-06 | 180 | 109 | 6 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.43e-06 | 180 | 109 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-06 | 180 | 109 | 6 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-06 | 180 | 109 | 6 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-06 | 181 | 109 | 6 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-06 | 181 | 109 | 6 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.78e-06 | 182 | 109 | 6 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.78e-06 | 182 | 109 | 6 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.78e-06 | 182 | 109 | 6 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.78e-06 | 182 | 109 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 5.78e-06 | 182 | 109 | 6 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 5.97e-06 | 183 | 109 | 6 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 5.97e-06 | 183 | 109 | 6 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| Computational | Neighborhood of EGFR | 2.45e-05 | 32 | 58 | 4 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 3.53e-05 | 35 | 58 | 4 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 7.33e-05 | 42 | 58 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.05e-04 | 46 | 58 | 4 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.35e-04 | 49 | 58 | 4 | GNF2_KISS1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.46e-04 | 50 | 58 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.46e-04 | 50 | 58 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_7 | |
| Computational | Neighborhood of RAB10 | 3.54e-04 | 176 | 58 | 6 | GCM_RAB10 | |
| Computational | Neighborhood of CDKN1C | 3.98e-04 | 27 | 58 | 3 | GNF2_CDKN1C | |
| Disease | tumor necrosis factor receptor superfamily member 19 measurement | 1.23e-05 | 2 | 104 | 2 | EFO_0020808 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.51e-05 | 14 | 104 | 3 | DOID:10976 (biomarker_via_orthology) | |
| Disease | cortical surface area measurement | MON2 TRPM6 GDF5 DAND5 SLC12A8 CACHD1 TG FZD9 NCOR1 THBS1 FBN1 ADAMTS9 ARHGAP31 MACF1 PAPPA RPS6KL1 | 1.91e-05 | 1345 | 104 | 16 | EFO_0010736 |
| Disease | Knee pain | 3.68e-05 | 3 | 104 | 2 | HP_0030839 | |
| Disease | leucine-rich repeats and immunoglobulin-like domains protein 3 measurement | 3.68e-05 | 3 | 104 | 2 | EFO_0020534 | |
| Disease | macrophage-capping protein measurement | 3.68e-05 | 3 | 104 | 2 | EFO_0020549 | |
| Disease | C-C motif chemokine 24 measurement | 7.35e-05 | 4 | 104 | 2 | EFO_0020197 | |
| Disease | scoliosis (implicated_via_orthology) | 1.22e-04 | 5 | 104 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | glucagon measurement, glucose tolerance test | 1.83e-04 | 6 | 104 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Age-related cataract | 1.83e-04 | 6 | 104 | 2 | HP_0011141 | |
| Disease | voltage-dependent calcium channel subunit alpha-2/delta-3 measurement | 1.83e-04 | 6 | 104 | 2 | EFO_0802218 | |
| Disease | clusterin measurement | 2.55e-04 | 7 | 104 | 2 | EFO_0007655 | |
| Disease | r-spondin-3 measurement | 2.55e-04 | 7 | 104 | 2 | EFO_0021878 | |
| Disease | Neurodevelopmental Disorders | 3.34e-04 | 93 | 104 | 4 | C1535926 | |
| Disease | Liver Cirrhosis | 4.93e-04 | 103 | 104 | 4 | C0023890 | |
| Disease | X-12063 measurement | 5.24e-04 | 186 | 104 | 5 | EFO_0021283 | |
| Disease | Fibrosis, Liver | 5.30e-04 | 105 | 104 | 4 | C0239946 | |
| Disease | otitis media (is_marker_for) | 5.44e-04 | 10 | 104 | 2 | DOID:10754 (is_marker_for) | |
| Disease | f-box/LRR-repeat protein 4 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0802538 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 5.44e-04 | 10 | 104 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | cortical thickness | MON2 DIP2B DAND5 SLC12A8 TG FZD9 THBS1 FBN1 ADAMTS9 MACF1 TRIM36 CACNA2D3 | 5.55e-04 | 1113 | 104 | 12 | EFO_0004840 |
| Disease | corneal topography | 6.10e-04 | 109 | 104 | 4 | EFO_0004345 | |
| Disease | colon cancer (implicated_via_orthology) | 6.63e-04 | 11 | 104 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 7.46e-04 | 550 | 104 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 9.02e-04 | 121 | 104 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0802114 | |
| Disease | obesity (implicated_via_orthology) | 1.00e-03 | 215 | 104 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.23e-03 | 225 | 104 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | Germ Cell Cancer | 1.25e-03 | 15 | 104 | 2 | C0740345 | |
| Disease | Embryonal Neoplasm | 1.25e-03 | 15 | 104 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 1.25e-03 | 15 | 104 | 2 | C0027658 | |
| Disease | Germ cell tumor | 1.25e-03 | 15 | 104 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 1.25e-03 | 15 | 104 | 2 | C0205852 | |
| Disease | Cancer, Embryonal | 1.25e-03 | 15 | 104 | 2 | C0751364 | |
| Disease | Cancer, Embryonal and Mixed | 1.25e-03 | 15 | 104 | 2 | C0751365 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 1.26e-03 | 60 | 104 | 3 | EFO_0022282 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.32e-03 | 61 | 104 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Vertigo | 1.51e-03 | 139 | 104 | 4 | HP_0002321 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.52e-03 | 64 | 104 | 3 | DOID:4947 (is_marker_for) | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.60e-03 | 239 | 104 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | 1-Methylhistidine measurement | 1.62e-03 | 17 | 104 | 2 | EFO_0021543 | |
| Disease | total lipids in very large HDL measurement | 1.66e-03 | 66 | 104 | 3 | EFO_0022312 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.71e-03 | 144 | 104 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.72e-03 | 243 | 104 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | interstitial lung disease | 1.73e-03 | 67 | 104 | 3 | EFO_0004244 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 1.88e-03 | 69 | 104 | 3 | EFO_0007788, EFO_0008002 | |
| Disease | cholesterol in very large HDL measurement | 1.88e-03 | 69 | 104 | 3 | EFO_0022229 | |
| Disease | maximal midexpiratory flow rate | 2.24e-03 | 20 | 104 | 2 | EFO_0004313 | |
| Disease | total lipids in large HDL | 2.30e-03 | 74 | 104 | 3 | EFO_0022189 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.47e-03 | 264 | 104 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | hemoglobin A1 measurement | 2.48e-03 | 520 | 104 | 7 | EFO_0007629 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.51e-03 | 160 | 104 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Corneal astigmatism | 2.58e-03 | 77 | 104 | 3 | EFO_1002040 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.58e-03 | 670 | 104 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | free cholesterol in large HDL measurement | 2.77e-03 | 79 | 104 | 3 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 2.87e-03 | 80 | 104 | 3 | EFO_0021900 | |
| Disease | chronic widespread pain | 2.97e-03 | 23 | 104 | 2 | EFO_0010099 | |
| Disease | brain connectivity measurement | 2.97e-03 | 400 | 104 | 6 | EFO_0005210 | |
| Disease | high density lipoprotein particle size measurement | 3.13e-03 | 170 | 104 | 4 | EFO_0008592 | |
| Disease | systemic scleroderma | 3.41e-03 | 85 | 104 | 3 | EFO_0000717 | |
| Disease | Dwarfism | 3.50e-03 | 25 | 104 | 2 | C0013336 | |
| Disease | medial orbital frontal cortex volume measurement | 3.50e-03 | 25 | 104 | 2 | EFO_0010315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AMLLSPTCLPVACTG | 61 | Q6ZRM9 | |
| MVPREAPESAQCLCP | 1 | Q8WTP8 | |
| IPTVISLASIMCCPE | 146 | B9A014 | |
| MADTQCCPPPCEFIS | 1 | Q9H0P7 | |
| IIPTGSVVIPSPCCM | 21 | O00175 | |
| CSSSSEMQPLPVGPC | 36 | A8MQ03 | |
| TRCMEGNPIPDTPCQ | 1416 | O95477 | |
| MAECSTPLPEDCSPT | 2386 | Q12802 | |
| PNLIDCLMVSPACST | 426 | Q8IY22 | |
| PLTAIQDCCTIPPSM | 121 | Q5VU97 | |
| LPCGPCIPIMLVLAT | 26 | Q6UWD8 | |
| PVPNSDAVLNCPACM | 171 | Q56P03 | |
| ACMPTPQSLGEPTEC | 76 | Q07507 | |
| VNCSMAQIQLCPPPP | 801 | P08603 | |
| PVLPASMIDIVCCPT | 931 | P78524 | |
| MVTNLPCSVTLQPGP | 116 | P36575 | |
| APITTVVTMGCEPQC | 2861 | Q9HC84 | |
| SSLCKVEIVCPPQSP | 251 | Q8WXH6 | |
| CCSERLPGLPQPIVM | 26 | P54829 | |
| SQTLGCQPMCTCPPA | 5136 | Q99102 | |
| VGCMPPPVSSAVILT | 111 | Q0GE19 | |
| GSDPTPLVLCNSCMP | 136 | Q8N907 | |
| MLISEACVPSVPCPL | 556 | Q9NSB2 | |
| MDPESTPPTCCVPTR | 456 | P43026 | |
| PVIPLLPTCMASAEQ | 351 | Q8WXG6 | |
| PLPKQTCDVITCEPM | 1626 | Q86YW9 | |
| MTPLCLNCSVLPGDL | 1 | Q9HB89 | |
| TPLMEQYVPCPVCET | 1156 | Q38SD2 | |
| RLSVIPTPTCDSPQM | 781 | Q6UXM1 | |
| TLMVACVSPSAQCLP | 331 | Q96FN5 | |
| MECCLPAEDSVKPNP | 501 | O43150 | |
| CQPMACLPSVCLPTT | 41 | Q14532 | |
| ILGCPMVLAPCSDSR | 526 | Q8N3T1 | |
| MWTTPPLCLEPCTLS | 571 | P05160 | |
| NIPDSPMANSGPLCC | 701 | Q9H1B7 | |
| CELPLLTPCSKAVMS | 66 | P15036 | |
| LIPPKSVNPTCMCCQ | 161 | Q8IW50 | |
| MQLRPTEPLPSQCCG | 16 | Q6IPT4 | |
| ILMCPHTCVTNLPKP | 931 | Q9P265 | |
| MSVDPACPQSLPCFE | 1 | Q9H9S0 | |
| TACTVEMPPLSPCLS | 281 | O94854 | |
| APCCVPASYNPMVLI | 271 | Q99988 | |
| IEQCSMCAVLSPPPQ | 791 | A8MYU2 | |
| VVPASQCCTPAMLFP | 326 | Q9BRR3 | |
| LVVTDFLPTMPCTCL | 931 | Q7Z3U7 | |
| FLPTMPCTCLQIVVD | 936 | Q7Z3U7 | |
| SFPEALCELMCLAPP | 1336 | Q13219 | |
| PPMLCPASLNICSVV | 391 | Q0VG06 | |
| NMTVPCPTEGCSLEL | 941 | Q9BXP8 | |
| VCSPLCVIPPSDPVM | 1676 | Q9BXP8 | |
| TEQVSTPIPACRVMC | 96 | Q9ULW2 | |
| TDQVSTPIPACRPMC | 101 | O00144 | |
| TDQDCSMSPCPQRTP | 1286 | Q9P2N4 | |
| DCTPAIMNIVLSQPC | 651 | Q8NFZ0 | |
| PSLCSPAGCMTILPT | 1766 | Q9P2D3 | |
| CVSVFPLECPALPMI | 146 | P20023 | |
| PEIINCCLTPEMLPV | 516 | Q8NF50 | |
| SCLCESVAPITMAPI | 1016 | Q8IZS8 | |
| VPPASSQPVQTCCLL | 71 | Q96PV7 | |
| RPNMCTCPSGQIAPS | 96 | P35555 | |
| LCSMDVRLPSPDCPF | 136 | P29279 | |
| CPPMTSATCLLAARV | 156 | Q9H1R2 | |
| GTMLPCFCPTEQALA | 206 | Q9BUX1 | |
| LQCMPVCGRPVTPIA | 226 | Q9NZP8 | |
| PVLPASMIDIVCSPT | 726 | Q68D51 | |
| SCCVPDPMGLSFLPT | 181 | A6NNA5 | |
| TDSPPMCEAIKCPEL | 561 | P16109 | |
| MNASCCLPSVQPTLP | 1 | P41968 | |
| CCRIEGDTISQVMPP | 6 | Q9BXC0 | |
| SRQMACTPISCPGEL | 791 | Q13751 | |
| CRSLVPMNTPICVVC | 256 | Q9NVP4 | |
| PMNTPICVVCEAPLA | 261 | Q9NVP4 | |
| SMCSCSLTPVPEPVL | 406 | A0AV02 | |
| PCLMTECSGTSQPPP | 156 | Q9Y5R6 | |
| MASQFCLPESPCLSP | 1 | Q8N4N8 | |
| VCEPNLCPMPLLNCA | 2041 | Q3ZCN5 | |
| SPVCSCPQLPFMLSP | 6 | O15225 | |
| LSVPCPDTQDFQPCM | 476 | Q9HCB6 | |
| AATAIMCDLCKPPPQ | 151 | Q9NQ86 | |
| PSELLSVPMQAFPCC | 1621 | O60522 | |
| MKTLETQPLAPDCCP | 1 | Q9BUR4 | |
| ELMFQPCAPCPLTCD | 1816 | A2VEC9 | |
| PVTCDSEMLTPDFCP | 826 | Q5TCX8 | |
| MSVDPACPQSLPCFE | 1 | Q6NSW7 | |
| VIPPMVSCTPCNIPI | 936 | O75376 | |
| SVNVSVICPSPSMLP | 296 | O60938 | |
| MACSRPPSQCEPTSL | 1 | Q969X2 | |
| AMKICNEILTSPCSP | 831 | Q9BPX3 | |
| LLIMTNNPPPCSITQ | 96 | Q96PP4 | |
| PSGPLTLQVRMSCEC | 116 | Q9BZM4 | |
| RPCCQLPVMQEPGCT | 311 | Q9UBS8 | |
| NPQPCTVCMHTPKTE | 696 | Q15468 | |
| VSCPIMPCSNATVPD | 351 | P07996 | |
| EQVLPTLSCTPEPMT | 1421 | Q9BX84 | |
| ALCLINMGTPVSSCP | 786 | Q9NXC5 | |
| METLCAPQVCPLPLN | 666 | O15027 | |
| CPPSITNSMVDIPIV | 361 | Q8IZW8 | |
| PMCVCQDPTSCPAPI | 91 | P09486 | |
| CLPPPLIQACTMQQL | 151 | Q7L0R7 | |
| DLMVLCPLCTQPPDH | 111 | A6NK02 | |
| ITRCPMIPCYISSPD | 156 | P16035 | |
| ALPACPDTMVSLVVP | 1306 | Q5T1R4 | |
| MSLVACECLPSPGLE | 1 | Q9Y6S9 | |
| TCRVQSPCTPLMNPF | 71 | B3SHH9 | |
| DATAPCMCEGPTLSP | 1276 | Q2M1Z3 | |
| CFPTLSPFVLMSCDP | 276 | Q7Z5H5 | |
| NIVCPTAMESPCISG | 521 | Q8NEG5 | |
| SVQTCGPVRLLPSMC | 241 | Q9NS68 | |
| HLAPSCSSMQIPCPV | 3966 | Q7Z7G8 | |
| CSSMQIPCPVVAAEP | 3971 | Q7Z7G8 | |
| DEIPPETQSCSLMCP | 1111 | Q9C0I4 | |
| CPTELTQEKTCPVTP | 1286 | Q9C0I4 | |
| MRSEPSKLPTCPGSC | 911 | P01266 | |
| CPTLIALTMFDCPVS | 121 | A6PVS8 | |
| CCPILTPLEPMSPQQ | 786 | Q9UL68 |